IJO, Indian Journal of Ophthalmology

Visual Performance of a Novel Optical Design of a New Multifocal Intraocular Lens

Eytan Nov, MD; Alexander Rubowitz, MD; Nimrod Dar, MD; Tal Sharon, MD; Ehud I. Assia, MD
(2022)

A study of the Intensity SL trifocal IOL demonstrated strong visual outcomes, particularly in near and intermediate vision, with high patient satisfaction and minimal need for spectacles post-cataract surgery. Three months after implantation, patients achieved excellent distance and near visual acuities, with contrast sensitivity comparable to the normal population. The IOL provides a well-balanced visual experience across various distances.

Fill form to download article

First Name

Last Name

Phone Number

Country

Organization

Position

Accaptance

Signup to get first look at new products, publications and events

STAY INFORMED

Signup to get the first look at new products, publications, and events

Related publications

Therapeutic Advances in Ophthalmology

Efficacy, safety, and satisfaction in patients with a functional 5-focus pseudophakic lens 2 years after

Germán R. Bianchi

This ambispective, non-randomized study evaluated the visual performance, safety, and patient satisfaction of the Intensity SL (Hanita Lenses) five-focus pseudophakic intraocular lens (IOL) over a 24-month period. The study included 120 eyes of 60 patients who underwent femtosecond laser-assisted bilateral cataract surgery. At two years postoperatively, patients demonstrated excellent uncorrected visual acuity across far, intermediate, and near distances (binocular UDVA −0.05 ± 0.05 logMAR; UIVA 0.009 ± 0.05; UNVA 0.04 ± 0.06). Visual stability was maintained between the 6- and 24-month follow-ups. Dysphotopsias such as glare and halos were rare and mild. Patient satisfaction was remarkably high, with 95% reporting being "very satisfied" and 100% indicating they would choose the same IOL again. The findings support the long-term visual efficacy and quality-of-life benefits of the Intensity SL IOL.

Nature Eye

Clinical outcomes with a new diffractive multifocal intraocular lens optimized by the dynamic light utilization algorithm

Jorge L. Alió et al.

This study assessed the refractive outcomes, optical performance, and quality of vision in patients implanted with the Intensity Hanita diffractive intraocular lens (IOL). The prospective, observational study included 64 eyes that underwent bilateral cataract surgery with Intensity IOL implantation, with evaluations conducted at 6 months post-surgery. Results indicated that 66% of eyes achieved uncorrected distance visual acuity (UDVA) of 0.10 logMAR or better. The defocus curve showed optimal vision at distance (0.02 ± 0.07 logMAR at 0.0 D) with stable performance through intermediate and near vision ranges (0.11 ± 0.08 logMAR at -1.5 D, 0.12 ± 0.12 logMAR at -2.5 D). Contrast sensitivity remained stable (p ≥ 0.06), and high-order aberrations were low, with a Strehl ratio of 0.12 ± 0.04. Mild halos and glare were reported but did not interfere significantly with daily activities, and the near activity visual questionnaire (NAVQ) indicated high patient satisfaction with near-vision tasks. These findings support the Intensity Hanita IOL’s effectiveness in providing clear vision across all distances through a five-foci distribution design that enhances depth of focus.

BMC Ophthalmology

Clinical results with a multifocal intraocular lens with a novel optical design

Gustavo Goldman

This study examined the optical performance and safety of a newly designed multifocal intraocular lens (IOL) with five focal points (two additional "intensifiers") for cataract and presbyopia management. Conducted in Buenos Aires and Ramos Mejia, Argentina, the prospective, non-randomized observational study included 31 patients (61 eyes) who received bilateral implantation between March 2020 and November 2021. At the 3-month follow-up, all eyes achieved an uncorrected distance visual acuity (UCDVA) of at least 0.15 logMAR, with 93% achieving 0.1 logMAR and 44% achieving 0.0 logMAR. For intermediate vision at 80 cm, 98% of eyes achieved at least 0.1 logMAR, and 79% reached 0.0 logMAR. The results highlight the new multifocal IOL’s efficacy, particularly for intermediate and near vision, with high rates of spectacle independence and patient satisfaction.